195 related articles for article (PubMed ID: 17372681)
1. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.
Stecová J; Mehnert W; Blaschke T; Kleuser B; Sivaramakrishnan R; Zouboulis CC; Seltmann H; Korting HC; Kramer KD; Schäfer-Korting M
Pharm Res; 2007 May; 24(5):991-1000. PubMed ID: 17372681
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting.
Ghasemiyeh P; Azadi A; Daneshamouz S; Heidari R; Azarpira N; Mohammadi-Samani S
Pharm Dev Technol; 2019 Sep; 24(7):812-823. PubMed ID: 30889371
[TBL] [Abstract][Full Text] [Related]
3. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
Münster U; Nakamura C; Haberland A; Jores K; Mehnert W; Rummel S; Schaller M; Korting HC; Zouboulis ChC; Blume-Peytavi U; Schäfer-Korting M
Pharmazie; 2005 Jan; 60(1):8-12. PubMed ID: 15700772
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
5. Local inhibition of sebaceous gland growth by topically applied RU 58841.
Matias JR; Gaillard M
Ann N Y Acad Sci; 1995 Jun; 761():56-65. PubMed ID: 7625751
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
Maia CS; Mehnert W; Schäfer-Korting M
Int J Pharm; 2000 Mar; 196(2):165-7. PubMed ID: 10699710
[TBL] [Abstract][Full Text] [Related]
7. Novel vesicular and particulate drug delivery systems for topical treatment of acne.
Castro GA; Ferreira LA
Expert Opin Drug Deliv; 2008 Jun; 5(6):665-79. PubMed ID: 18532922
[TBL] [Abstract][Full Text] [Related]
8. Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery.
Hanna PA; Ghorab MM; Gad S
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(1):26-44. PubMed ID: 30430947
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne.
Gupta S; Wairkar S; Bhatt LK
J Microencapsul; 2020 Dec; 37(8):557-565. PubMed ID: 32924680
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
[TBL] [Abstract][Full Text] [Related]
12. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.
Gruber DM; Sator MO; Joura EA; Kokoschka EM; Heinze G; Huber JC
Arch Dermatol; 1998 Apr; 134(4):459-63. PubMed ID: 9554298
[TBL] [Abstract][Full Text] [Related]
13. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids.
Valenta C; Janisch M
Int J Pharm; 2003 Jun; 258(1-2):133-9. PubMed ID: 12753760
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Vartiainen M; de Gezelle H; Broekmeulen CJ
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
[TBL] [Abstract][Full Text] [Related]
17. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Bitzer J; Römer T; Lopes da Silva Filho A
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):172-182. PubMed ID: 28447864
[TBL] [Abstract][Full Text] [Related]
18. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
19. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment.
Jain AK; Jain A; Garg NK; Agarwal A; Jain A; Jain SA; Tyagi RK; Jain RK; Agrawal H; Agrawal GP
Colloids Surf B Biointerfaces; 2014 Sep; 121():222-9. PubMed ID: 25016424
[TBL] [Abstract][Full Text] [Related]
20. Different effectiveness of cyproterone acetate doses in treatment of acne.
De Leo V; Morgante G
Clin Endocrinol (Oxf); 2003 Feb; 58(2):246. PubMed ID: 12580942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
